Literature DB >> 15790332

Quality of life in childhood epilepsy: validating the QOLCE.

A M Connolly, M Sabaz, J A Lawson, A M E Bye, D R Cairns.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15790332     DOI： 10.1111/j.1440-1754.2005.570_2.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN： 1034-4810            Impact factor:   1.954


× No keyword cloud information.
  4 in total

1.  Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol.

Authors:  Evan C Rosenberg; Jay Louik; Erin Conway; Orrin Devinsky; Daniel Friedman
Journal:  Epilepsia       Date:  2017-06-15       Impact factor: 5.864

Review 2.  Quality of life in children with adverse drug reactions: a narrative and systematic review.

Authors:  Blanca R Del Pozzo-Magaña; Michael J Rieder; Alejandro Lazo-Langner
Journal:  Br J Clin Pharmacol       Date:  2015-07-02       Impact factor: 4.335

3.  The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study.

Authors:  Darren Reithmeier; Richard Tang-Wai; Blair Seifert; Andrew W Lyon; Jane Alcorn; Bryan Acton; Scott Corley; Erin Prosser-Loose; Darrell D Mousseau; Hyun J Lim; Jose Tellez-Zenteno; Linda Huh; Edward Leung; Lionel Carmant; Richard J Huntsman
Journal:  BMC Pediatr       Date:  2018-07-07       Impact factor: 2.125

4.  Connectomic profiling and Vagus nerve stimulation Outcomes Study (CONNECTiVOS): a prospective observational protocol to identify biomarkers of seizure response in children and youth.

Authors:  Lauren Siegel; Han Yan; Nebras Warsi; Simeon Wong; Hrishikesh Suresh; Alexander G Weil; John Ragheb; Shelly Wang; Curtis Rozzelle; Gregory W Albert; Jeffrey Raskin; Taylor Abel; Jason Hauptman; Dewi V Schrader; Robert Bollo; Matthew D Smyth; Sean M Lew; Melissa Lopresti; Dominic J Kizek; Howard L Weiner; Aria Fallah; Elysa Widjaja; George M Ibrahim
Journal:  BMJ Open       Date:  2022-04-08       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.